Calreticulin immunoreactivity also appeared to distribute to a larger fiber population in biopsies of Group I and Group II myositis patients (Figure 2m to 2o) than that one of healthy subjects, whereas staining of biopsies of Group III patients (Figure 2p) was comparable with that of Group 0 subjects. Here, CALR is linked to myositis disease.